Does PEMBROLIZUMAB Cause Product administration error? 14 Reports in FDA Database

Q: Does PEMBROLIZUMAB cause Product administration error?

14 reports of Product administration error have been filed with the FDA for PEMBROLIZUMAB, representing 0.0% of all PEMBROLIZUMAB adverse event reports.

Q: How dangerous is Product administration error from PEMBROLIZUMAB?

Of 14 reports, 1 (7.1%) resulted in death and 3 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Product administration error have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.

Reports of Product administration error with PEMBROLIZUMAB

0.0%

of all PEMBROLIZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Product administration error From PEMBROLIZUMAB?

Of the 14 reports, 1 (7.1%) resulted in death, 3 (21.4%) required hospitalization, and 3 (21.4%) were considered life-threatening.

Is Product administration error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does PEMBROLIZUMAB Cause?

Malignant neoplasm progression (10,111) Death (4,744) Diarrhoea (4,251) Fatigue (3,833) Off label use (3,416) Product use in unapproved indication (3,191)